HYMOVIS

HYMOVIS 24mg / 3ml pre-filled syringe N2

Composition:

HYADD 4 (sodium hexadecylamide hyaluronate)

Dosage:

Hexadecylamide sodium hyaluronate 24 mg / 3 ml

Cod ATC:

M09AX01

Therapeutic indications:

Treatment of pain in osteoarthritic joints
Conservative treatment of the meniscal lesion of the knee
Improvement of joint mobility through the enhancement of synovial fluid viscoelasticity
Treatment of degenerative or mechanical arthropathy of the hip and knee joints.

Description:

HYMOVIS is an innovative product, a new generation hyaluronic acid which improves the function of lubrication and cushioning of the synovial fluid, protecting cartilage and soft tissues from mechanical damage. These properties, together with the increased residence time in the joints, allow HYMOVIS to reduce pain and improve joint function in a short-term treatment regimen.

Manufacturer

Fidia Farmaceutici S.p.A. Via Ponte della Fabbrica 3/A – 35031 Abano Terme (PD) – Italy

Pharmacovigilance

Information about drug safety

Pharmacovigilance is the science and activities related to the detection, evaluation, understanding and prevention of adverse effects or any other problem related to medicines.